Cargando…
Assessment of the accuracy of an intermittent‐scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study
FreeStyle Libre has been approved for use in patients undergoing hemodialysis (HD) in Japan, unlike Europe and the United States; however, evidence regarding its accuracy in such patients is sparse. Forty‐one participants with type 2 diabetes undergoing HD were recruited. The overall mean absolute r...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495855/ https://www.ncbi.nlm.nih.gov/pubmed/33403763 http://dx.doi.org/10.1111/1744-9987.13618 |
| _version_ | 1784579635347980288 |
|---|---|
| author | Toyoda, Masao Murata, Takashi Saito, Nobumichi Kimura, Moritsugu Takahashi, Hiroo Ishida, Naoto Kitamura, Makoto Hida, Miho Hayashi, Akinori Moriguchi, Ibuki Kobayashi, Naoyuki Tsuriya, Daisuke Sakao, Yukitoshi Matsushita, Takaya Ito, Yukie Suzuki, Shota Kasama, Shu Kasahara, Masato Yamakawa, Tadashi Mori, Katsuhito Kuroda, Akio Miura, Junnosuke Hirota, Yushi Abe, Masanori Fukagawa, Masafumi Sakane, Naoki Hosoda, Kiminori |
| author_facet | Toyoda, Masao Murata, Takashi Saito, Nobumichi Kimura, Moritsugu Takahashi, Hiroo Ishida, Naoto Kitamura, Makoto Hida, Miho Hayashi, Akinori Moriguchi, Ibuki Kobayashi, Naoyuki Tsuriya, Daisuke Sakao, Yukitoshi Matsushita, Takaya Ito, Yukie Suzuki, Shota Kasama, Shu Kasahara, Masato Yamakawa, Tadashi Mori, Katsuhito Kuroda, Akio Miura, Junnosuke Hirota, Yushi Abe, Masanori Fukagawa, Masafumi Sakane, Naoki Hosoda, Kiminori |
| author_sort | Toyoda, Masao |
| collection | PubMed |
| description | FreeStyle Libre has been approved for use in patients undergoing hemodialysis (HD) in Japan, unlike Europe and the United States; however, evidence regarding its accuracy in such patients is sparse. Forty‐one participants with type 2 diabetes undergoing HD were recruited. The overall mean absolute relative difference and mean absolute difference were 23.4% and 33.9 mg/dL, respectively. Sensor glucose levels and capillary glucose levels were significantly correlated (r = 0.858, P < .01), although the sensor glucose levels were significantly lower than the capillary glucose levels. The accuracy of FreeStyle Libre in patients undergoing HD became deteriorated with the days of usage. The percentage of sensor results in Zones A and B in the consensus error grid analysis and in the Clarke error grid analysis were 99.7% and 99.0%, respectively. Its insufficient accuracy necessitates adjunct usage of FreeStyle Libre with self‐monitoring of blood glucose in patients undergoing HD. |
| format | Online Article Text |
| id | pubmed-8495855 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley & Sons Australia, Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84958552021-10-12 Assessment of the accuracy of an intermittent‐scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study Toyoda, Masao Murata, Takashi Saito, Nobumichi Kimura, Moritsugu Takahashi, Hiroo Ishida, Naoto Kitamura, Makoto Hida, Miho Hayashi, Akinori Moriguchi, Ibuki Kobayashi, Naoyuki Tsuriya, Daisuke Sakao, Yukitoshi Matsushita, Takaya Ito, Yukie Suzuki, Shota Kasama, Shu Kasahara, Masato Yamakawa, Tadashi Mori, Katsuhito Kuroda, Akio Miura, Junnosuke Hirota, Yushi Abe, Masanori Fukagawa, Masafumi Sakane, Naoki Hosoda, Kiminori Ther Apher Dial Original Articles FreeStyle Libre has been approved for use in patients undergoing hemodialysis (HD) in Japan, unlike Europe and the United States; however, evidence regarding its accuracy in such patients is sparse. Forty‐one participants with type 2 diabetes undergoing HD were recruited. The overall mean absolute relative difference and mean absolute difference were 23.4% and 33.9 mg/dL, respectively. Sensor glucose levels and capillary glucose levels were significantly correlated (r = 0.858, P < .01), although the sensor glucose levels were significantly lower than the capillary glucose levels. The accuracy of FreeStyle Libre in patients undergoing HD became deteriorated with the days of usage. The percentage of sensor results in Zones A and B in the consensus error grid analysis and in the Clarke error grid analysis were 99.7% and 99.0%, respectively. Its insufficient accuracy necessitates adjunct usage of FreeStyle Libre with self‐monitoring of blood glucose in patients undergoing HD. John Wiley & Sons Australia, Ltd 2021-02-02 2021-10 /pmc/articles/PMC8495855/ /pubmed/33403763 http://dx.doi.org/10.1111/1744-9987.13618 Text en © 2021 The Authors. Therapeutic Apheresis and Dialysis published by John Wiley & Sons Australia, Ltd on behalf of International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Original Articles Toyoda, Masao Murata, Takashi Saito, Nobumichi Kimura, Moritsugu Takahashi, Hiroo Ishida, Naoto Kitamura, Makoto Hida, Miho Hayashi, Akinori Moriguchi, Ibuki Kobayashi, Naoyuki Tsuriya, Daisuke Sakao, Yukitoshi Matsushita, Takaya Ito, Yukie Suzuki, Shota Kasama, Shu Kasahara, Masato Yamakawa, Tadashi Mori, Katsuhito Kuroda, Akio Miura, Junnosuke Hirota, Yushi Abe, Masanori Fukagawa, Masafumi Sakane, Naoki Hosoda, Kiminori Assessment of the accuracy of an intermittent‐scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study |
| title | Assessment of the accuracy of an intermittent‐scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study |
| title_full | Assessment of the accuracy of an intermittent‐scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study |
| title_fullStr | Assessment of the accuracy of an intermittent‐scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study |
| title_full_unstemmed | Assessment of the accuracy of an intermittent‐scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study |
| title_short | Assessment of the accuracy of an intermittent‐scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study |
| title_sort | assessment of the accuracy of an intermittent‐scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (aidt2h) study |
| topic | Original Articles |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495855/ https://www.ncbi.nlm.nih.gov/pubmed/33403763 http://dx.doi.org/10.1111/1744-9987.13618 |
| work_keys_str_mv | AT toyodamasao assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT muratatakashi assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT saitonobumichi assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT kimuramoritsugu assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT takahashihiroo assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT ishidanaoto assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT kitamuramakoto assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT hidamiho assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT hayashiakinori assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT moriguchiibuki assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT kobayashinaoyuki assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT tsuriyadaisuke assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT sakaoyukitoshi assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT matsushitatakaya assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT itoyukie assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT suzukishota assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT kasamashu assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT kasaharamasato assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT yamakawatadashi assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT morikatsuhito assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT kurodaakio assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT miurajunnosuke assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT hirotayushi assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT abemasanori assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT fukagawamasafumi assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT sakanenaoki assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy AT hosodakiminori assessmentoftheaccuracyofanintermittentscanningcontinuousglucosemonitoringdeviceinpatientswithtype2diabetesmellitusundergoinghemodialysisaidt2hstudy |